Streetbeat News

Price Targets

SMR

NuScale Power shares rose after Craig-Hallum initiated coverage with a Buy rating and a $16 price target.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 5:13 pm

TTE

TD Cowen analyst Jason Gabelman maintains a Hold rating on TotalEnergies (NYSE:TTE) and raises the price target from $72 to $74.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 5:12 pm

INMB

Raymond James has initiated coverage on INmune Bio (NASDAQ:INMB) with an Outperform rating and set a price target of $18.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 5:11 pm

LENZ

Raymond James has initiated coverage on LENZ Therapeutics with an Outperform rating and set a price target of $37.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 5:09 pm

ACHV

Raymond James has initiated coverage on Achieve Life Sciences with a Strong Buy rating and set a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 5:06 pm

TSLA

Tech analyst Dan Ives from Wedbush expects Tesla's Q3 deliveries to exceed expectations, driven by strong demand in China. He anticipates positive catalysts like the upcoming Robotaxi event and believes Tesla's price cuts are mostly over, with gross margins set to rebound. Wedbush maintains an Outperform rating and a $300 price target for Tesla.

Portfolio Pulse from Erica Kollmann

September 27, 2024 | 5:02 pm

CERT

Certara (NASDAQ:CERT) has received mixed analyst ratings over the past three months, with a recent average price target of $17.5, down from $19.50. Analysts have adjusted their ratings and price targets in response to market conditions, reflecting a range of perspectives from bullish to bearish. Certara's financial performance shows a 3.17% revenue growth, a net margin of -13.48%, and a debt-to-equity ratio of 0.3.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 5:01 pm

PHR

Phreesia (NYSE:PHR) has received diverse analyst ratings over the past three months, with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has slightly increased to $29.00. Analysts have adjusted their ratings and price targets, reflecting their responses to Phreesia's recent performance and market conditions. Phreesia has shown strong revenue growth and effective debt management, but faces challenges with net margin and asset utilization.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 5:01 pm

ZETA

DA Davidson analyst Clark Wright maintains a Buy rating on Zeta Global Holdings with a $35 price target.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 4:09 pm

POWW

Roth MKM analyst Matt Koranda maintains a Neutral rating on AMMO (NASDAQ:POWW) and lowers the price target from $1.6 to $1.5.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 4:08 pm